Analyse the current network topology implemented at ‘Lucent Pharma’ and identify five major…

This assignment consists of two parts. Part 1 relates to the improvement of the network security posture of an organisation and is worth 25 marks. This part will mainly test your knowledge that you will gain during the lectures and study materials that are available through Blackboard. Part 2 of the assignment is worth 15 marks and will test your hands-on experience on the use of cybersecurity tools such as ‘Nmap’ (Network Mapper) and ‘Wireshark’. You are encouraged to use a Virtual Machine, preferably ‘Kali Linux’, and start looking for various resources for information on the use and deployment of these tools. You are also encouraged to make maximum use of the ‘Lynda Campus’ resource freely accessible on the Student Portal to get you started on both parts. Also, you should start coming to grips with the use of Virtual Machine software such as ‘VMWare’ and how to open a ‘Kali Linux’ machine within a VM from the first week of the semester. It is also worth mentioning that the final exam is designed to test your knowledge and skills developed through this course, of which, the major assignment is an integral part. Part 1 (Network Design): ‘Lucent Pharma’ is a pharmaceutical firm based in Perth and has two offices in two different suburbs. The firm’s current network topology was deployed in haste and as such does not have any effective security control. The CEO of the firm has started feeling the concerns around the cyber security of its network, as Lucent Pharma’s business is flourishing, and competitors are also becoming more and more active in the region. The current network topology of Lucent Pharma is given in Figure 1. Requirement: As a network security consultant, you are required to: 1. Analyse the current network topology implemented at ‘Lucent Pharma’ and identify five major vulnerabilities that exist in the network. You are also required to provide sound reasoning behind these identified vulnerabilities. (3 marks) 2. Place the following security devices/controls, bearing in mind that these devices do not compromise either the network performance or the security of the network: a. Firewall b. IDS/IPS c. Honeypot d. Routers/Switches e. Other devices that may add value to the ‘Lucent Pharma’ network Semester 1, 2018 Page 2 of 5 3. Explain/Justify why these devices were placed in the chosen locations in (2)? (5 marks for 2 and 3) 4. Does the Lucent Pharma network require segregation into multiple domains (i.e. requirement of VLANs)? If yes, please add these additional sub-networks to yourtopology. (3 marks) 5. Create a set of firewall policies and a set of firewall rules that should be implemented by the network administrator for firewall(s) placed in the network. Policies must be sound and robust to cover the cyber-security of the entire network. (2 marks) 6. Create a set of IDS/IPS policies and corresponding rules that are to be implemented by the